img

Global Eosinophilic Esophagitis Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Eosinophilic Esophagitis Treatment Market Research Report 2024

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.
According to MRAResearch’s new survey, global Eosinophilic Esophagitis Treatment market is projected to reach US$ 190.3 million in 2033, increasing from US$ 129.8 million in 2022, with the CAGR of 5.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Eosinophilic Esophagitis Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Eosinophilic Esophagitis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AstraZeneca
GSK
Bayer
Segment by Type
Budesonide
Fluticasone

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Eosinophilic Esophagitis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eosinophilic Esophagitis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Budesonide
1.2.3 Fluticasone
1.3 Market by Application
1.3.1 Global Eosinophilic Esophagitis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eosinophilic Esophagitis Treatment Market Perspective (2018-2033)
2.2 Eosinophilic Esophagitis Treatment Growth Trends by Region
2.2.1 Global Eosinophilic Esophagitis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Eosinophilic Esophagitis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Eosinophilic Esophagitis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Eosinophilic Esophagitis Treatment Market Dynamics
2.3.1 Eosinophilic Esophagitis Treatment Industry Trends
2.3.2 Eosinophilic Esophagitis Treatment Market Drivers
2.3.3 Eosinophilic Esophagitis Treatment Market Challenges
2.3.4 Eosinophilic Esophagitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eosinophilic Esophagitis Treatment Players by Revenue
3.1.1 Global Top Eosinophilic Esophagitis Treatment Players by Revenue (2018-2023)
3.1.2 Global Eosinophilic Esophagitis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Eosinophilic Esophagitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Eosinophilic Esophagitis Treatment Revenue
3.4 Global Eosinophilic Esophagitis Treatment Market Concentration Ratio
3.4.1 Global Eosinophilic Esophagitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eosinophilic Esophagitis Treatment Revenue in 2022
3.5 Eosinophilic Esophagitis Treatment Key Players Head office and Area Served
3.6 Key Players Eosinophilic Esophagitis Treatment Product Solution and Service
3.7 Date of Enter into Eosinophilic Esophagitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eosinophilic Esophagitis Treatment Breakdown Data by Type
4.1 Global Eosinophilic Esophagitis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Type (2024-2033)
5 Eosinophilic Esophagitis Treatment Breakdown Data by Application
5.1 Global Eosinophilic Esophagitis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Eosinophilic Esophagitis Treatment Market Size (2018-2033)
6.2 North America Eosinophilic Esophagitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
6.4 North America Eosinophilic Esophagitis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Eosinophilic Esophagitis Treatment Market Size (2018-2033)
7.2 Europe Eosinophilic Esophagitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
7.4 Europe Eosinophilic Esophagitis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Eosinophilic Esophagitis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Eosinophilic Esophagitis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Eosinophilic Esophagitis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Eosinophilic Esophagitis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Eosinophilic Esophagitis Treatment Market Size (2018-2033)
9.2 Latin America Eosinophilic Esophagitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
9.4 Latin America Eosinophilic Esophagitis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eosinophilic Esophagitis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Eosinophilic Esophagitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Eosinophilic Esophagitis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Eosinophilic Esophagitis Treatment Introduction
11.1.4 AstraZeneca Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Eosinophilic Esophagitis Treatment Introduction
11.2.4 GSK Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Eosinophilic Esophagitis Treatment Introduction
11.3.4 Bayer Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.3.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Eosinophilic Esophagitis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Budesonide
Table 3. Key Players of Fluticasone
Table 4. Global Eosinophilic Esophagitis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Eosinophilic Esophagitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Eosinophilic Esophagitis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Eosinophilic Esophagitis Treatment Market Share by Region (2018-2023)
Table 8. Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Eosinophilic Esophagitis Treatment Market Share by Region (2024-2033)
Table 10. Eosinophilic Esophagitis Treatment Market Trends
Table 11. Eosinophilic Esophagitis Treatment Market Drivers
Table 12. Eosinophilic Esophagitis Treatment Market Challenges
Table 13. Eosinophilic Esophagitis Treatment Market Restraints
Table 14. Global Eosinophilic Esophagitis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Eosinophilic Esophagitis Treatment Market Share by Players (2018-2023)
Table 16. Global Top Eosinophilic Esophagitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Treatment as of 2022)
Table 17. Ranking of Global Top Eosinophilic Esophagitis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Eosinophilic Esophagitis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Eosinophilic Esophagitis Treatment Product Solution and Service
Table 21. Date of Enter into Eosinophilic Esophagitis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Eosinophilic Esophagitis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Eosinophilic Esophagitis Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Eosinophilic Esophagitis Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Eosinophilic Esophagitis Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Eosinophilic Esophagitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Eosinophilic Esophagitis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Eosinophilic Esophagitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Eosinophilic Esophagitis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Eosinophilic Esophagitis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Eosinophilic Esophagitis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Eosinophilic Esophagitis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Eosinophilic Esophagitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Eosinophilic Esophagitis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Eosinophilic Esophagitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Eosinophilic Esophagitis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. AstraZeneca Company Detail
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca Eosinophilic Esophagitis Treatment Product
Table 49. AstraZeneca Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023) & (US$ Million)
Table 50. AstraZeneca Recent Development
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK Eosinophilic Esophagitis Treatment Product
Table 54. GSK Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Bayer Company Detail
Table 57. Bayer Business Overview
Table 58. Bayer Eosinophilic Esophagitis Treatment Product
Table 59. Bayer Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023) & (US$ Million)
Table 60. Bayer Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eosinophilic Esophagitis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Eosinophilic Esophagitis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Budesonide Features
Figure 4. Fluticasone Features
Figure 5. Global Eosinophilic Esophagitis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Eosinophilic Esophagitis Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Eosinophilic Esophagitis Treatment Report Years Considered
Figure 11. Global Eosinophilic Esophagitis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Eosinophilic Esophagitis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Eosinophilic Esophagitis Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Eosinophilic Esophagitis Treatment Market Share by Players in 2022
Figure 15. Global Top Eosinophilic Esophagitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Eosinophilic Esophagitis Treatment Revenue in 2022
Figure 17. North America Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Eosinophilic Esophagitis Treatment Market Share by Country (2018-2033)
Figure 19. United States Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Eosinophilic Esophagitis Treatment Market Share by Country (2018-2033)
Figure 23. Germany Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Eosinophilic Esophagitis Treatment Market Share by Region (2018-2033)
Figure 31. China Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Eosinophilic Esophagitis Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Eosinophilic Esophagitis Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Eosinophilic Esophagitis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. AstraZeneca Revenue Growth Rate in Eosinophilic Esophagitis Treatment Business (2018-2023)
Figure 46. GSK Revenue Growth Rate in Eosinophilic Esophagitis Treatment Business (2018-2023)
Figure 47. Bayer Revenue Growth Rate in Eosinophilic Esophagitis Treatment Business (2018-2023)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries